Whereas UV-detection is predominant in the larger systems, its sensitivity is inadequate due to the minute pathlengths employed in a chip. This review summarizes the shortcomings of UV detection, and discusses some possible solutions. Besides, it presents an overview of the alternative detection methods that have been employed in pharmaceutical and chiral chip analysis, including their positive and negative aspects as well. Finally,
CH5183284 the applications reported on the chips are discussed.”
“BACKGROUND: Heat removal is one of the major constraints in large-scale solid-state fermentation (SSF) processes. The effect of internal air circulation by forced convection on heat and water transfer has not been studied in SSF tray bioreactors. Formulation of a mathematical LY2835219 inhibitor model for SSF requires a good estimation of the mass and heat transfer coefficients.
RESULTS: A stainless steel tray bioreactor (80.6 L capacity) was used. Aspergillus niger C28B25 was cultivated under SSF conditions on an inert support. Temperature, moisture content, biomass and substrate concentrations were measured. Water and energy integral balances were used
to estimate the heat and mass transfer coefficients involved in the process. The Reynolds number (N(Re)) in the headspace of the tray bioreactor ranged from 2.5 to 2839, which increased the global heat transfer coefficient from 4.2 to 6.9 (Wm(-2) K(-1)) and the mass transfer coefficient from 1.0 to 2.1 (gm(-2) s(-1)). Mathematical model predictions of the temperature and moisture content of the fermentation bed showed a high goodness-of-fit with the experimental results.
CONCLUSIONS: This is the first report describing the effect of N(Re) of air in the headspace of a SSF tray bioreactor on the heat and mass transfer coefficients and temperature regulation in SSF. (C) 2011 Society of Chemical Industry”
“Protrusion of the Amplatzer duct occluder (ADO) II device into the aortic isthmus or the pulmonary artery causing
obstruction and residual flow has been reported, but the same has not been widely studied in small children with a patent ductus arteriosus (PDA) anatomy not considered AL3818 ic50 suitable for closure with the ADO I device. This study aimed to report the safety and efficacy of the ADO II device in children younger than 3 years with a tubular or elongated PDA and to analyze the possible reasons for residual flow in children with such a PDA. In this study, 17 children younger than 3 years (mean age, 10.3 +/- 7 months; mean weight, 6 +/- 3.6 kg) underwent attempted closure of a tubular or elongated PDA (mean diameter at the narrowest point, 4.1 +/- 1.1 mm) with the ADO II device between July 2010 and July 2012. Of the 17 patients, 16 (2 boys and 14 girls) completed the follow-up evaluation.